Hifibio - High Fidelity Biology
Hifibio - High Fidelity Biology is a single cell technologies for drug discovery founded in 2013 by Liang Schweizer, Jeff He and Robert Nicol.
4
Funding Rounds
$179.5m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Li*** Sc******* | - | - | |
| Je** He | - | - | |
| Ro**** Ni*** | - | - |
Funding series
Funding Series Analysis
The company Hifibio - High Fidelity Biology has raised a total of $75m in funding over 4 rounds.
Key Insights:
- Hifibio - High Fidelity Biology Series D round, June 2021: $75m
- HiFiBiO Therapeutics funding round, May 2018: $37.5m
- HiFiBio Therapeutics funding round, August 2019: $67m
Hifibio - High Fidelity Biology Series D round, June 2021
$75m
HiFiBiO Therapeutics funding round, May 2018
$37.5m
HiFiBio Therapeutics funding round, August 2019
$67m
Industries
Hifibio - High Fidelity Biology is active in the following industries: